Genmab

Genmab is a Danish listed biotech company specialising in differentiated human antibody therapeutics for the treatment of cancer.

  • Kempen & Co acted as placement agent in Genmab’s 2015 cashless warrant exercise 
Disclaimer Kempen Privacy statement Kempen Disclaimer Kempen & Co Privacy statement Kempen & Co Statement under the UK Modern Slavery Act Cookie Settings
Kempen & Co is a trade name of Van Lanschot Kempen Wealth Management NV. Both Van Lanschot Kempen Wealth Management NV and Kempen Capital Management NV are part of Van Lanschot Kempen NV